INSEAD Day 4 - 728x90

booster

Google to invest $6.4bn

The investment is its biggest-ever in Germany.

Pfizer poised to buy Metsera

The pharma giant improved its offer to $10bn.

Ozempic maker lowers outlook

The company posted tepid Q3 results.

Kimberly-Clark to buy Kenvue

The deal is valued at $48.7 billion.

BYD Q3 profit down 33%

This was a 33% year-on-year decrease.
  • The WHO's vaccine experts are no longer recommending additional Covid-19 vaccine booster doses for regular, medium-risk adults because the benefit was marginal. The experts said that for such people who have received their primary vaccination course and one booster dose, there is no risk in having further shots but the...